drug
SAR-BBN
Preclinicalupdated 3mo agoby Clarity Pharmaceuticals Ltd
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying SAR-BBN
- phase264Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)
- phase264Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that